TONIX PHARMACEUTICALS, INC.

NJ

biotechnology company--pharmaceuticals development and manufacturing

Filings
32
Firms Hired
1
Total Expenses
—
Years Active
2017–2025

Filings

All 202520242023202220212020201920182017
YearFirmPeriodExpensesDoc
2025 CARDINAL POINT PARTNERS 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report (No Activity) 		—
2025 CARDINAL POINT PARTNERS 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report (No Activity) 		—
2024 CARDINAL POINT PARTNERS 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report 		—
2024 CARDINAL POINT PARTNERS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report 		—
2024 CARDINAL POINT PARTNERS 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report 		—
2024 CARDINAL POINT PARTNERS 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		—
2023 CARDINAL POINT PARTNERS 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report 		—
2023 CARDINAL POINT PARTNERS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report 		—
2023 CARDINAL POINT PARTNERS 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report 		—
2023 CARDINAL POINT PARTNERS 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		—
Page 1 of 4  ·  32 filings Next
Firms Hired
FirmFilingsExpenses
CARDINAL POINT PARTNERS 32 —
Issue Areas
IssueActivities
Defense 19
Budget/Appropriations 14
Disaster Planning/Emergencies 14
Veterans 8
Health Issues 4

Bills Mentioned in Filings

S.3799 H.R. 4365 S. 2333 H.R. 8774 S. 3062 H.R. 7900 HR925 H.R. 8236 H.R. 4502 H.R. 8295 HR 2500 H.R. 2968 S. 1790 S.785 S. 4921 S. 4638 S. 4942 S. 2587 H.R. 9029 H.R. 8070 H.R. 2617 S. 4543 HR 7614 H.R. 7776 HR 1219